These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23402421)

  • 21. Antifungal lipopeptides from Bacillus amyloliquefaciens strain BO7.
    Romano A; Vitullo D; Di Pietro A; Lima G; Lanzotti V
    J Nat Prod; 2011 Feb; 74(2):145-51. PubMed ID: 21235220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclo(L-Pro-D-Arg): a new antibacterial and antitumour diketopiperazine from Bacillus cereus associated with a rhabditid entomopathogenic.
    Kumar SN; Mohandas C; Nambisan B; Sreerag RS; Jayaprakas CA
    Folia Microbiol (Praha); 2014 May; 59(3):197-202. PubMed ID: 24097052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and synergistic antibacterial activity of arginine derived cyclic dipeptides, from Achromobacter sp. associated with a rhabditid entomopathogenic nematode against major clinically relevant biofilm forming wound bacteria.
    Deepa I; Kumar SN; Sreerag RS; Nath VS; Mohandas C
    Front Microbiol; 2015; 6():876. PubMed ID: 26379651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusarihexins A and B: Novel Cyclic Hexadepsipeptides from the Mangrove Endophytic Fungus Fusarium sp. R5 with Antifungal Activities.
    Zhu X; Zhong Y; Xie Z; Wu M; Hu Z; Ding W; Li C
    Planta Med; 2018 Dec; 84(18):1355-1362. PubMed ID: 29954027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid.
    Ström K; Sjögren J; Broberg A; Schnürer J
    Appl Environ Microbiol; 2002 Sep; 68(9):4322-7. PubMed ID: 12200282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Purification and characterization of antifungal peptide LP-1].
    Liu Y; Xu Q; Chen Z
    Wei Sheng Wu Xue Bao; 1999 Oct; 39(5):441-7. PubMed ID: 12555526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifungal quinazolinones from marine-derived Bacillus cereus and their preparation.
    Xu Z; Zhang Y; Fu H; Zhong H; Hong K; Zhu W
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4005-7. PubMed ID: 21612927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR spectroscopic and MS/MS spectrometric characterization of a new lipopeptide antibiotic bacillopeptin B1 produced by a marine sediment-derived Bacillus amyloliquefaciens SH-B74.
    Ma Z; Hu J; Wang X; Wang S
    J Antibiot (Tokyo); 2014 Feb; 67(2):175-8. PubMed ID: 24064466
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxysporidinone: a novel, antifungal N-methyl-4-hydroxy-2-pyridone from Fusarium oxysporum.
    Breinhold J; Ludvigsen S; Rassing BR; Rosendahl CN; Nielsen SE; Olsen CE
    J Nat Prod; 1997 Jan; 60(1):33-5. PubMed ID: 9014349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Thermotolerant Marine
    Singh P; Xie J; Qi Y; Qin Q; Jin C; Wang B; Fang W
    Mar Drugs; 2021 Sep; 19(9):. PubMed ID: 34564178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saoussanabiloïde, a novel antifungal alkaloid from Echiochilon fruticosum Desf. growing in Tunisia.
    Hammami S; Mighri N; Ben Jannet H; Boughalleb N; Zardi-Bergaoui A; Nefzi A; Abreu P; Mighri Z
    Nat Prod Res; 2009; 23(16):1466-71. PubMed ID: 19844820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of an antifungal compound produced by Bacillus sp. strain A(5) F that inhibits Sclerotinia sclerotiorum.
    Kumar A; Saini S; Wray V; Nimtz M; Prakash A; Johri BN
    J Basic Microbiol; 2012 Dec; 52(6):670-8. PubMed ID: 22359152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry identification of antifungal lipopeptides from Bacillus sp. BCLRB2 against Rhizoctonia solani and Sclerotinia sclerotiorum.
    Elkahoui S; Djébali N; Karkouch I; Ibrahim AH; Kalai L; Bachkovel S; Tabbene O; Limam F
    Prikl Biokhim Mikrobiol; 2014; 50(2):184-8. PubMed ID: 25272736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacillus amyloliquefaciens Q-426 as a potential biocontrol agent against Fusarium oxysporum f. sp. spinaciae.
    Zhao P; Quan C; Wang Y; Wang J; Fan S
    J Basic Microbiol; 2014 May; 54(5):448-56. PubMed ID: 23553741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis FR-2.
    Kajimura Y; Sugiyama M; Kaneda M
    J Antibiot (Tokyo); 1995 Oct; 48(10):1095-103. PubMed ID: 7490214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and identification of antifungal N-butylbenzenesulphonamide produced by Pseudomonas sp. AB2.
    Kim KK; Kang JG; Moon SS; Kang KY
    J Antibiot (Tokyo); 2000 Feb; 53(2):131-6. PubMed ID: 10805572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopeptide biosurfactant from Bacillus thuringiensis pak2310: A potential antagonist against Fusarium oxysporum.
    Deepak R; Jayapradha R
    J Mycol Med; 2015 Mar; 25(1):e15-24. PubMed ID: 25456418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ultrasound-assisted extraction and identification of antifungal substances from B. amyloliquefaciens strain NJN-6 suppressing Fusarium oxysporum.
    Yuan J; Raza W; Huang Q; Shen Q
    J Basic Microbiol; 2012 Dec; 52(6):721-30. PubMed ID: 22581589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonistic Activities of Novel Peptides from Bacillus amyloliquefaciens PT14 against Fusarium solani and Fusarium oxysporum.
    Kim YG; Kang HK; Kwon KD; Seo CH; Lee HB; Park Y
    J Agric Food Chem; 2015 Dec; 63(48):10380-7. PubMed ID: 26496638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two piperazic acid-containing cyclic hexapeptides from Streptomyces alboflavus 313.
    Wei S; Fan L; Wu W; Ji Z
    Amino Acids; 2012 Nov; 43(5):2191-8. PubMed ID: 22543750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.